← board
PBH
distress 0/10 · well-funded / low risk$48.49-1%today-37% from 52w high
Revenue
$1089M
Liquidity
$64M
Runway
—
Shares 1y
-4%
Price & events
-28.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.1%
1D
-4.2%
1W
+5.3%
1M
-16.1%
3M
-26.3%
6M
-36.8%
1Y
-31.6%
2Y
-7.8%
5Y
+34.1%
All
Overview
- Market Cap
- $2.30B
- Enterprise Value
- $3.23B
- Volume
- 15.49K
- 52 Week Range
- $45.44 – $76.88
- Total Shares
- 47.37M
- Float Shares
- 46.69M
- Short %
- 8.18%
- % Held by Insiders
- 1.38%
- % Held by Institutions
- 113.97%
- RVOL
- 0.02x
- Beta
- 0.35
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2026-08-06Estimated 45%earningsEarningsEarnings releaseyahoo
- 2026-03-19partnershipDefinitive agreement to acquire Foundation Consumer Brands' OTC portfolio including Breathe Right for $1.045B cash.SEC 8-K
- 2025-08-04partnershipAcquisition of Pillar5 Pharma Inc. for CAD 150M cash.SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-05-15Canaccord GenuityBuy
- 2026-05-14OppenheimerOutperform → Perform
- 2026-05-07OppenheimerOutperform
- 2026-02-02JefferiesHold
- 2025-11-07Canaccord GenuityBuy
- 2025-10-27JefferiesHold
Competitors
- none identified
Recent news
- 2026-07-20Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring A 33.81% Potential Upside - DirectorsTalk Interviews
- 2026-07-19how InvestingPro’s fair value spotted Prestige Healthcare’s 42% drop By Investing.com - Investing.com
- 2026-07-15Prestige Consumer Healthcare (NYSE: PBH) issues $400M 2034 notes - Stock Titan
- 2026-07-14John Rogers Increases Stake in Prestige Consumer Healthcare Inc - GuruFocus
- 2026-07-10Enterprise value to revenue forward of Prestige Consumer Healthcare Inc. – NYSE:PBH - TradingView
- 2026-07-09Prestige Consumer (NYSE: PBH) updates filing on OTC Wellness acquisition - Stock Titan
- 2026-07-07Ariel Investments reports 10.3% stake in Prestige Consumer Healthcare (PBH) - Stock Titan
- 2026-07-06Prestige Consumer Healthcare closes LaCorium acquisition for $150m By Investing.com - Investing.com Nigeria
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.